Find latest Bladder Cancer videos · 100+ videos
UCSF School of Medicine
V

Trastuzumab Deruxtecan Approval for Metastatic HER2+ Bladder Cancer

By UCSF School of Medicine FEATURING Vadim Koshkin
By UCSF School of Medicine FEATURING Vadim Koshkin
264 views
June 20, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Featured Video

17:48
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma With Mul…

Feat. R. Alter, A. Rezazadeh

Related Videos

Advanced Prostate Cancer Consensus Conference (APCCC)

APCCC 2026

Fri, Feb 27, 2026
20:41

Bladder Cancer Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

1.5K views
21:43

Surgical Management of High-Risk and Locally Advanced Prostate Cancer

Yale Cancer Center

I. Kim

465 views
10:11

Enhanced Diagnostics in Prostate Cancer: PSA and Beyond in 2024

Penn Medicine Abramson Cancer Center

D. Lee

295 views
08:54

ESMO 2024 Summary: GU Practice-Changing Trial Results of PEACE-3 (mC…

2024 ESMO Annual Meeting Insights Hub

R. Dreicer

344 views
16:05

Recent GU Developments and Their Clinical Implications

Insights from 2024 ASCO® GU Annual Meeting

T. Powles, B. Rini

1.5K views
14:16

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Messages"

Insights from 2024 ASCO® GU Annual Meeting

E. Efstathiou

2.6K views
08:54

Advances in Prostate Cancer Surgery

Penn Medicine Abramson Cancer Center

B. Schurhamer, T. Guzzo

224 views
21:08

Updates in the Treatment and Management of Bladder Cancer

Integrity CE

M. Galsky, B. Guercio

298 views
07:05

Avoiding Unnecessary Operations in Prostate Cancer

Penn Medicine Abramson Cancer Center

P. Pierorazio

198 views
19:00

Treatment (De)Intensification in RCC

International Urology Cancer Summit - IUCS

S. Kumar Pal

241 views
28:00

Review of Bladder Cancer Updates From ESMO 2024

The View on GU | with Lalani & Wallis

A. A. Lalani, C. Wallis

120 views
15:45

Evolving Strategies in First and Second-Line Treatment for mCRPC

International Urology Cancer Summit - IUCS

N. Agarwal

230 views
10:14

Ideal Treatment Sequence After ADT + ARPI + Docetaxel for mHSPC

Advanced Prostate Cancer Consensus Conference (APCCC)

K. Fizazi

187 views
16:25

Visible vs. Invisible Cancers - The Genomics and Natural History

Laurence Klotz

199 views
24:34

New

Practical Considerations for PSMA-Targeted Therapy in Prostate Cancer

University of Illinois Cancer Center

K. Tawagi, N. Reizine

174 views
07:40

ESMO 2024 Summary: Practice-Changing Trials for Patients With Locali…

2024 ESMO Annual Meeting Insights Hub

P. Grivas

256 views
19:29

New

Year in Review - Key Clinical Trials in Prostate Cancer

GWU Urology

179 views
29:25

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views
20:07

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

269 views
09:37

Total Therapy Considerations in Low-Volume mHSPC: Intensification vs…

Advanced Prostate Cancer Consensus Conference (APCCC)

O. Sartor

167 views
AUTOPLAY